neurodevelopment – Medxy AI

Maternal Diabetes and Early Neurodevelopment: Differential Risks Emerge Across Diabetes Types and Infant Sex

By MedXY 04/17/2026

A nationwide cohort study of 466,462 infants reveals that maternal pregestational diabetes significantly increases the risk of delayed developmental milestones, with type 1 diabetes conferring the highest risk and female offspring showing particular vulnerability across language, personal-social, and gross motor domains.

Clinical Updates news

Long-Term Academic Performance Following Prenatal Opioid Analgesic Exposure: A Population-Based Risk Assessment

By MedXY 03/30/2026

This review analyzes the association between in utero prescription opioid exposure and third-grade academic outcomes, highlighting a distinct risk signal for tramadol compared to codeine and oxycodone **Outlining Key Sections** I'm now structuring the "Clinical Updates" piece. I've drafted the background, focusing on the opioid epidemic and the need for pain management during pregnancy. I'm building out subsections for the Varney et al. study, emphasizing the reading/numeracy score data. The draft of the "Key Content" is coming together, and I will be working on addressing potential confounders to provide a comprehensive analysis. I am planning the structure of the "Expert Commentary" section. .

Cardiology news Pediatrics

Over 50% of Publicly Insured Children Face Neurodevelopmental Disorders Following Infant Heart Surgery

By MedXY 02/05/2026

A comprehensive study highlights that over half of publicly insured children develop neurodevelopmental disorders within five years of infant cardiac surgery. While service utilization is high, a critical gap persists between initial screening and specialized evaluations required for optimal outcomes.

Neurology news Pediatrics

Early Developmental Intervention Linked to Sustained Executive Function Gains in Very Preterm Children

By MedXY 01/26/2026

A secondary analysis of a randomized clinical trial reveals that parent-led enhanced developmental intervention, beginning in the NICU and spanning two years, significantly improves executive function domains—including attention, inhibition, and problem-solving—in very preterm children by age seven.

news Psychiatry

Deciphering Prenatal Risks: Why Maternal Health, Not Medication, Often Drives Neurodevelopmental Outcomes

By MedXY 01/25/2026

Recent large-scale cohort studies suggest that previously observed links between prenatal exposure to acid-suppressants or antipsychotics and neurodevelopmental disorders are largely due to familial confounding. Conversely, active maternal eating disorders remain a significant risk factor, highlighting the critical role of maternal health optimization.

news Pediatrics Psychiatry

Beyond Picky Eating: Large-Scale Study Reveals the Genetic Architecture and Developmental Impact of ARFI Phenotypes

By MedXY 01/06/2026

This large-scale study of 35,751 children characterizes ARFI phenotypes, revealing a 6.3% clinical prevalence and significant genetic heritability. Findings link ARFI to the ADCY3 locus and long-term neurodevelopmental difficulties, emphasizing the need for early identification and broad support interventions.

Hematology-Oncology news Pediatrics

Restrictive versus Liberal Transfusion Thresholds in Very Low Birthweight Infants: Fewer Transfusions Without Harm to Survival or Early Neurodevelopment

By MedXY 12/12/2025

A Cochrane meta-analysis of six RCTs (3,451 infants) finds restrictive hemoglobin thresholds reduce transfusion exposure modestly with no detectable effect on mortality or neurodevelopmental impairment at 18–26 months.

Clinical Updates news Pediatrics Respiratory

Hydrocortisone in Preterm Infants and School-Age Functional Outcomes: Comprehensive Review of Evidence from Randomized Clinical Trials

By MedXY 12/08/2025

Neonatal hydrocortisone treatment in preterm infants at high risk for bronchopulmonary dysplasia does not improve school-age functional outcomes, highlighting the persistent burden of developmental impairment despite intervention.

Nephrology news Pediatrics

Acute Kidney Injury in Extremely Preterm Infants Predicts Higher Risk of Death or Neurodevelopmental Impairment at Two Years

By MedXY 11/19/2025

Secondary analysis of the PENUT trial found that acute kidney injury (AKI) in infants born at 24–27 weeks’ gestation is independently associated with death or moderate to severe neurodevelopmental impairment at 22–26 months' corrected age.

Neurology news Psychiatry

Decoding the Genetic Complexity of Impulsivity and Its Neurodevelopmental Impact

By MedXY 10/29/2025

This study reveals the heterogeneous genetic architecture of impulsivity, uncovering diverse biological pathways linking it to neurodevelopment and psychopathology across the lifespan.

Pediatrics Psychiatry Public Health

Silent Long-Term Harm: How Prenatal Lead Exposure Shapes Adult Mental Health

By MedXY 10/24/2025

This article explores the link between prenatal and early postnatal lead exposure and adult anxiety and depression, emphasizing critical exposure windows and long-term mental health implications.

news Pediatrics Specialties

Long-Term Educational Trajectories After Preterm Birth: Unraveling the Roles of Biological and Sociodemographic Factors

By MedXY 10/01/2025

This study reveals that although individuals born preterm face higher risks of lower educational attainment, sociodemographic factors have a greater impact on long-term educational outcomes than prematurity itself.

Clinical Updates Neurology Specialties

Early-Life Gut Microbiome Maturity: A Key Regulator of Blood-Brain Barrier Integrity and Cognitive Development

By MedXY 09/29/2025

This study demonstrates that the maturity of the early-life gut microbiome influences blood-brain barrier integrity and cognitive functions, highlighting a novel therapeutic target for neurodevelopmental disorders.

Clinical Updates Neurology OB/GYN & Women's Health

Intranasal Mesenchymal Stromal Cells for Perinatal Arterial Stroke: Promising Safety and Improved Neurodevelopment at Two Years

By MedXY 09/22/2025

The PASSIoN study shows that intranasally administered allogeneic mesenchymal stromal cells in neonates with perinatal arterial ischemic stroke are safe up to two years and suggest better motor outcomes compared to untreated cohorts.

Clinical Updates Neurology news OB/GYN & Women's Health Specialties

Innovations in Prenatal Care: In Utero Embolization for Vein of Galen Malformation

By MedXY 09/10/2025

In utero embolization for fetal Vein of Galen malformation shows early promise in reducing mortality and neurodevelopmental delays, despite increased risk of preterm delivery.